Navigation Links
NexBio(R) Demonstrates DAS181 (Fludase(R)*), a Broad-Spectrum Drug Candidate, Inhibits Influenza Viral Infection in Human Lung Tissue
Date:8/25/2009

g and commercializing novel, broad-spectrum biopharmaceuticals to prevent and treat current and emerging life-threatening diseases. DAS181 (Fludase((R))), a recombinant fusion protein, inactivates viral receptors on the cells of the human respiratory tract, thereby preventing and treating infection by influenza, including potential pandemic strains, and by parainfluenza viruses (which may cause serious respiratory illness similar to influenza and for which there is no approved vaccine or therapeutic). Unlike current antiviral compounds and vaccines, DAS181 targets human host receptors, not virus components, and thus carries a reduced risk of drug resistance compared with currently-available antiviral drugs. Extensive, prolonged nonclinical studies have not shown the development of any meaningful resistance. Viradin((TM)), invented and developed by NexBio, is a parenteral protein under development, currently at lead optimization stage, directed to the treatment of viral hemorrhagic fevers and bacterial biothreat sepsis. TOSAP((TM)) is a technology invented and developed by NexBio and is used to formulate DAS181 for inhalation, as well as to make nano/microparticles from virtually any type of molecule. TOSAP((TM)) is offered for the formulation of compounds of partners, under license.

For more information about NexBio, Inc., please visit http://www.nexbio.com

    Contact:

    David Wurtman, M.D., M.B.A
    VP, Corporate Development
    10665 Sorrento Valley Road
    San Diego, CA  92121
    Phone: (858) 452-2631
    dwurtman@nexbio.com

* FDA has yet to approve the name Fludase.

DISCLOSURE NOTICE:

This release contains forward-looking information about the research and development program of
'/>"/>

SOURCE NexBio, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Data Published in Cell Stem Cell Demonstrates Potent Anti-Cancer Activity for OncoMed Pharmaceuticals Lead Antibody
2. Abbott HIV Test Demonstrates Earlier Disease Detection
3. BioNeutrals Ygiene(TM) Hospital Grade Antimicrobial Demonstrates a 99.9997% Kill Rate Against Clostridium Difficile Spores (C.diff) in Independent Lab Pre-testing Phase
4. New Pre-Clinical Data on OmniGuides BeamPath NEURO(TM) Demonstrates Precise Cutting in Brain Tissue
5. Phase II Trial Demonstrates Elacytarabine May Increase Survival Threefold in Patients With Late-Stage Leukaemia
6. PROSTVAC(TM) Data Presented at the ASCO Meeting Demonstrates the Potential for Significant Increases in Life Expectancy in Late-Stage Prostate Cancer
7. NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD & NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS
8. OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial
9. SemBioSys plant-derived Apo AI(Milano) demonstrates encouraging biologic activity in seven preclinical models
10. OrbusNeichs Genous(TM) Bio-engineered R stent(TM) Demonstrates Impressive Results in Higher Risk Patients
11. Finesse Demonstrates TruFluor(TM) pH, a Single-Use Optical pH Sensor and Transmitter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... and HILDEN, Germany ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... its QIAGEN Clinical Insight ® (QCI™) bioinformatics ... to interpret and report on genomic variants identified ... applications for the bioinformatics platform are in oncology, ...
(Date:5/26/2015)... CHENGDU, China , May 26, 2015 ... pharmaceutical company that specializes in the patented biopharmaceutical, modernized ... ingredients (API), announced that the Company,s Annual Meeting of ... was scheduled to be held at the Company,s office ... via conference call, at 9:00 AM (local time in ...
(Date:5/26/2015)... May 26, 2015  A simple blood test developed ... to detect early Alzheimer,s disease is a step closer ... Detailed standardized guidelines that are needed before a blood ... in Alzheimer,s & Dementia . The guidelines establish ... working group that includes UNT Health Science Center. ...
(Date:5/26/2015)... ANGELES , May 26, 2015 Mr. ... his family, thanks President Barack Obama and President ... during the time of loss of Dr. Rongxiang Xu ... humanitarian and a leader ahead of his time, Dr. Xu,s ... the community leave a legacy that will not be forgotten. ...
Breaking Biology Technology:QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 2QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 3QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 4QIAGEN Launches Clinical Bioinformatics Platform for Next-Generation Sequencing 5TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 2TPI Adjourned Its 2014 Annual Shareholder Meeting and Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements 3Guidelines bring UNT Health Science Center's blood test for Alzheimer's one step closer 2Dr. Rongxiang Xu, Beyond A Legend 2
... 9 Insmed Inc. (Nasdaq:,INSM), a developer of follow-on ... Therapeutics, will present at the,Collins Stewart Fourth Annual Growth ... in New York., The conference will take place ... Tuesday, July 8 through Thursday, July 10. Insmed,s,presentation will ...
... Inc.,(OTC Bulletin Board: CAGC) ("China Agritech" or "the ... today announced that it,has entered into a contract ... Ezz,Group, a distributor of agricultural and fertilizer products ... Group began working with China Agritech over a ...
... MARINO, Calif., July 9 Epeius Biotechnologies,Corporation today ... by the U.S. Food and Drug Administration (FDA) ... latest approval is the third,clinical indication for which ... the United States. This latest approval for Rexin-G ...
Cached Biology Technology:Insmed to Present at Collins Stewart Fourth Annual Growth Conference 2China Agritech to Export Products to Egypt 2China Agritech to Export Products to Egypt 3FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas 2FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas 3
(Date:4/27/2015)... LAUDERDALE, Fla. , Apr. 27, 2015 ... of access control and security systems is pleased to ... the company as a consultant and member of its ... is widely known as a thought leader in ... Distance Learning Technology Group, and has published studies and ...
(Date:4/14/2015)... April 14, 2015  HYPR Corp. today announced ... ® ) Alliance tm , an industry consortium ... commit to share technology and collaborate to deliver ... interoperable, more secure and private, and easier to ... verification that protects sensitive user information and eliminates ...
(Date:4/9/2015)... , April 9, 2015 Synaptics Inc. (NASDAQ: ... solutions, announced today that it will report financial results ... April 23, 2015, after the close of market. The ... and investors at 2:00 p.m. PT (5:00 p.m. ET), ... To participate on the live call, analysts and ...
Breaking Biology News(10 mins):Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3Synaptics to Report Third Quarter Results on April 23 2
... in the Bahamas, ancient visitors took up residence in ... stark evidence that the arrival of humans can permanently ... been isolated islands, says a University of Florida researcher. ... water-filled sinkhole called a blue hole revealed the bones ...
... seeing Garfield-sized cats, obese, middle-aged cats can have a ... fatal. The causes of diabetes mellitus in cats remain ... whether a dry food diet puts cats at greater ... of Missouri-Columbia veterinarian suggests that weight gain, not the ...
... over-the-counter product for topical wound care is more effective ... MRSA, which is potentially deadly and in recent years ... much broader public concern. A new laboratory study ... a product made with benzethonium chloride kills common types ...
Cached Biology News:Fossils excavated from Bahamian blue hole may give clues of early life 2Fossils excavated from Bahamian blue hole may give clues of early life 3Choosing dry or wet food for cats makes little difference 2Best treatment identified to reduce deadly Staph infections 2Best treatment identified to reduce deadly Staph infections 3
... Analysis Note: Evaluated for its amino acid acceptor ... amino acids Ala, Asp, Gly, Ile, Lys, Pro, ... Tyr. Preparation Unit Definition: One unit will yield ... ml of water (1 cm light path). ...
... lication: For use as a ... and precipitation. Physical form: Solution ... pH 7.4, 1 mM EDTA ... precipitated Concentration: ...
... Immobilized White solid. PACKAGED UNDER INERT ... on polyacrylamide resin with applications similar to those ... 233156 , and 233155 ) but ... are added to the system. REDUCTACRYL™ Reagent can ...
... DTT White crystalline solid. PACKAGED ... titration. Contaminants: DNases, proteases, RNases: ... 260 nm): ≤0.500; (100 mM, 1 cm, ... ≤0.001%. Soluble in H 2 O. ...
Biology Products: